MPM BioImpact LLC 13D and 13G filings for Compass Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:11 pm Purchase | 2024-12-31 | 13G | Compass Therapeutics, Inc. CMPX | MPM BioImpact LLC | 8,567,896 6.200% | 8,567,896 (New Position) | Filing |